Skip to main content
. 2017 Aug 2;2017(8):CD001324. doi: 10.1002/14651858.CD001324.pub5
Methods Randomised, double‐blind, multicentre trial. Random number generation done centrally, double‐blinded by use of identical placebos
Participants 200 healthy women recruited in the study from an obs/gyn clinic in Wuhan, China
Included women with regular menstrual periods, aged 22‐42 years, who had attended the clinic within 72 h of a single act of unprotected intercourse
Excluded women who were on hormonal contraception in the current cycle and those with uncertain dates of last menstrual period
Interventions Mife 10 mg, single dose vs Mife 25 mg, orally
Outcomes Observed number of pregnancies, side effects and changes in menstrual pattern
Notes
  1. Post‐randomisation exclusion and loss to follow‐up not reported

  2. Observed pregnancy/expected pregnancy/total number of women: Mife 10 mg 1/10/100; Mife 25 mg 1/10/100

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Random number generation done centrally
Allocation concealment (selection bias) Unclear risk Method of allocation concealment not mentioned
Blinding (performance bias and detection bias) All outcomes Low risk Double‐blind
Incomplete outcome data (attrition bias) All outcomes Unclear risk Post‐randomisation exclusion and loss to follow‐up not reported
Selective reporting (reporting bias) Low risk Reported planned outcomes
Other bias Low risk None detected